NL8901432A - Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan. - Google Patents

Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan. Download PDF

Info

Publication number
NL8901432A
NL8901432A NL8901432A NL8901432A NL8901432A NL 8901432 A NL8901432 A NL 8901432A NL 8901432 A NL8901432 A NL 8901432A NL 8901432 A NL8901432 A NL 8901432A NL 8901432 A NL8901432 A NL 8901432A
Authority
NL
Netherlands
Prior art keywords
calcium
complexing agent
folinate
solution
ions
Prior art date
Application number
NL8901432A
Other languages
English (en)
Dutch (nl)
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Priority to NL8901432A priority Critical patent/NL8901432A/nl
Priority to IL92370A priority patent/IL92370A0/xx
Priority to US07/440,129 priority patent/US5177076A/en
Priority to AT90201353T priority patent/ATE83660T1/de
Priority to EP90201353A priority patent/EP0401895B1/en
Priority to DE9090201353T priority patent/DE69000645T2/de
Priority to ES199090201353T priority patent/ES2036396T3/es
Priority to DK90201353.1T priority patent/DK0401895T3/da
Priority to FI902712A priority patent/FI96275C/fi
Priority to CA002018230A priority patent/CA2018230C/en
Priority to NO902487A priority patent/NO176389C/no
Priority to AU56297/90A priority patent/AU626421B2/en
Priority to JP2146384A priority patent/JP2945718B2/ja
Publication of NL8901432A publication Critical patent/NL8901432A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NL8901432A 1989-06-06 1989-06-06 Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan. NL8901432A (nl)

Priority Applications (13)

Application Number Priority Date Filing Date Title
NL8901432A NL8901432A (nl) 1989-06-06 1989-06-06 Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
IL92370A IL92370A0 (en) 1989-06-06 1989-11-20 Aqueous folinate solution stable at refrigerator temperature and process for its preparation
US07/440,129 US5177076A (en) 1989-06-06 1989-11-21 Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation
AT90201353T ATE83660T1 (de) 1989-06-06 1990-05-28 Bei kuehlschranktemperatur stabile waessrige folinatloesung sowie verfahren zu deren herstellung.
EP90201353A EP0401895B1 (en) 1989-06-06 1990-05-28 Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation
DE9090201353T DE69000645T2 (de) 1989-06-06 1990-05-28 Bei kuehlschranktemperatur stabile waessrige folinatloesung sowie verfahren zu deren herstellung.
ES199090201353T ES2036396T3 (es) 1989-06-06 1990-05-28 Solucion acuosa de folinato estable a la temperatura del refrigerador asi como proceso para su preparacion.
DK90201353.1T DK0401895T3 (da) 1989-06-06 1990-05-28 Vandig folinatopløsning, som er stabil ved køleskabstemperatur samt fremgangsmåde til dens fremstilling
FI902712A FI96275C (fi) 1989-06-06 1990-05-31 Menetelmä stabiilin vesipitoisen kalsiumfolinaattiliuoksen valmistamiseksi
CA002018230A CA2018230C (en) 1989-06-06 1990-06-04 Aqueous folinate solution - stable at refrigerator temperature, as well as process for its preparation
NO902487A NO176389C (no) 1989-06-06 1990-06-05 Fremgangsmåte ved fremstilling av vandig folinatlösning stabil ved kjöleskapstemperatur
AU56297/90A AU626421B2 (en) 1989-06-06 1990-06-05 Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation
JP2146384A JP2945718B2 (ja) 1989-06-06 1990-06-06 冷蔵庫温度で安定なホリニン酸塩水溶液並びにその製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8901432 1989-06-06
NL8901432A NL8901432A (nl) 1989-06-06 1989-06-06 Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.

Publications (1)

Publication Number Publication Date
NL8901432A true NL8901432A (nl) 1991-01-02

Family

ID=19854784

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8901432A NL8901432A (nl) 1989-06-06 1989-06-06 Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.

Country Status (13)

Country Link
US (1) US5177076A (da)
EP (1) EP0401895B1 (da)
JP (1) JP2945718B2 (da)
AT (1) ATE83660T1 (da)
AU (1) AU626421B2 (da)
CA (1) CA2018230C (da)
DE (1) DE69000645T2 (da)
DK (1) DK0401895T3 (da)
ES (1) ES2036396T3 (da)
FI (1) FI96275C (da)
IL (1) IL92370A0 (da)
NL (1) NL8901432A (da)
NO (1) NO176389C (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684644A5 (de) 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
CN1047076C (zh) * 1993-04-28 1999-12-08 吉富制药株式会社 稳定的注射剂及注射剂的稳定方法
CH687062A5 (de) * 1994-02-14 1996-09-13 Cerbios Pharma Sa Konzentrierte Injektionsloesung von Alkalimetallsalzen von reduzierten Folaten.
NL9400530A (nl) 1994-04-05 1995-11-01 Pharmachemie Bv Stabiele waterige folinaatoplossing.
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
WO2002085297A2 (en) * 2001-04-24 2002-10-31 East Carolina University Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
US7405207B2 (en) * 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
EP1553954A4 (en) * 2002-06-17 2009-12-23 Epigenesis Pharmaceuticals Llc DIHYDRATE DEHYDROEPIANDROSTERONE AND METHOD FOR THE TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE LUNG DISEASE, COMPOSITIONS THEREOF
US20050026884A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026881A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
US20090263381A1 (en) * 2003-07-31 2009-10-22 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090297611A1 (en) * 2003-07-31 2009-12-03 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
US20050043282A1 (en) * 2003-07-31 2005-02-24 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090285899A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20050113318A1 (en) * 2003-07-31 2005-05-26 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090285900A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026848A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20050101545A1 (en) * 2003-07-31 2005-05-12 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
CH696717A5 (de) * 2004-02-20 2007-10-31 Cerbios Pharma Sa Konzentrierte, stabile Losung, insbesondere eine Injektionslosung oder Infusionslosung, welche nebst Wasser entweder (6S)-Natrium-Folinat oder (6S)-Kalium-Folinat entholt
KR20060051135A (ko) * 2004-09-15 2006-05-19 니프로 가부시키가이샤 안정화된 주사용 수용액 제재
US9713616B2 (en) 2012-08-06 2017-07-25 Spectrum Pharmaceuticals, Inc. Pharmaceutical compositions comprising L-leucovorin
CN120617167B (zh) * 2025-07-25 2026-03-24 连云港众维生物医药有限公司 提高亚叶酸钙注射液稳定性非最终灭菌生产工艺及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2695860A (en) * 1952-04-29 1954-11-30 American Cyanamid Co Stabilized pteroyl solutions
GB1572137A (en) * 1977-02-22 1980-07-23 Bioresearch Sas Del Dr Livio C Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts
US4344940A (en) * 1981-11-30 1982-08-17 E. R. Squibb & Sons, Inc. Steroid formulation containing dipotassium EDTA
US4436738A (en) * 1982-03-15 1984-03-13 Mead Johnson & Company Stabilized estradiol cream composition

Also Published As

Publication number Publication date
NO902487L (no) 1990-12-07
JP2945718B2 (ja) 1999-09-06
EP0401895B1 (en) 1992-12-23
ES2036396T3 (es) 1993-05-16
US5177076A (en) 1993-01-05
AU626421B2 (en) 1992-07-30
FI96275B (fi) 1996-02-29
DK0401895T3 (da) 1993-04-13
AU5629790A (en) 1990-12-13
ATE83660T1 (de) 1993-01-15
FI96275C (fi) 1996-06-10
FI902712A0 (fi) 1990-05-31
CA2018230C (en) 1996-04-16
CA2018230A1 (en) 1990-12-06
DE69000645T2 (de) 1993-05-13
JPH0356418A (ja) 1991-03-12
EP0401895A1 (en) 1990-12-12
DE69000645D1 (de) 1993-02-04
NO176389B (no) 1994-12-19
NO902487D0 (no) 1990-06-05
IL92370A0 (en) 1990-07-26
NO176389C (no) 1995-03-29

Similar Documents

Publication Publication Date Title
NL8901432A (nl) Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
US4931441A (en) Stabilized aqueous leucovorin calcium compositions
SU1482509A3 (ru) Способ стабилизации пироксикама
KR950703988A (ko) 긴 보장기간을 갖는 g-csf의 수성 약제 조성물(aqueous pharmaceutical preparations of g-csf whth a long shelf life)
JP3043381B2 (ja) 葉酸及びロイコボリン塩類の安定で注射液として使用できる薬剤及びその製造方法
US2695860A (en) Stabilized pteroyl solutions
SK862004A3 (en) Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
NL8901433A (nl) Carboplatinpreparaat.
US4931442A (en) Stabilized aqueous folic acid preparation
EP0801571B1 (en) Soluble 2-chloro-2'-deoxyadenosine formulations
AU684350B2 (en) Stable aqueous folinate solution
JP3146218B2 (ja) 点眼剤
EP0397147B1 (en) Stable solutions of rebeccamycin analog and preparation thereof
EA039525B1 (ru) Фосфаплатиновые жидкие составы
CA2029368C (en) Injectable solution and process for preparing same
US3530216A (en) Vitamin compositions comprising riboflavin-5-phosphate and ferric pyrophosphate soluble
US4301160A (en) Ready for use, injectable, aqueous solutions of alkali metal salts of canrenoic acid and furosemide and process for their preparation
RU2063227C1 (ru) Лекарственное средство для лечения сердечно-сосудистых заболеваний и способ его получения
JPS63179827A (ja) アデノシン三リン酸とマグネシウムイオンを含む安定な製剤
Angehrn et al. Investigations on the mode of action of the combination sulfamethoxazole/trimethoprim
US4988722A (en) Parenteral compositions
White et al. The effect of pH upon the antitumor activity and delayed lethal toxicity of nitrogen mustard
CN119343131A (zh) 包含5,10-亚甲基-(6r)-四氢叶酸钠的浓缩溶液
JPS5914005B2 (ja) マイトマイシンｃの安定化法
CN119365217A (zh) 奥来毒素制剂

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed